Profitability
Weight: 15%
B-
67
- 5yr Avg ROIC 22.2%
- Operating Margin Trend -32.72 pp/yr
BNTX
BioNTech SE
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 2 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
A
89
- 5yr Avg ROE 19.7%
- 5yr Share-Count CAGR -1.8%
Growth Quality
Weight: 35%
F
8
- 5yr Revenue CAGR -38.3%
- 5yr EPS CAGR -69.5%
- Revenue-Growth Years (5) 2/5
Cash Generation
Weight: 20%
A
90
- 5yr FCF Margin 40.7%
- 5yr FCF/NI Conversion 2.16x
Balance Sheet
Weight: 10%
F
25
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -73.00x
- Altman Z-Score 6.89
Stability
Weight: 5%
F
23
- EPS Volatility (σ/μ) 1.05
- Piotroski F-Score 4
- Negative-Revenue Years (5) 3/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.1 of 2 gurus held; 1 trimmed; 1 full exit.
- Holders
- 1 -1
- Avg Δ position
- -59.1%
- New buys
- 0
- Full exits
- 1